Extracts from artemisia annua plant found to be active against SARS-CoV-2 virus under laboratory conditions

A team of researchers affiliated with institutions in Denmark, Germany and Hong Kong has found that several extracts from the artemisia annua plant are active against the SARS-CoV-2 virus under laboratory conditions. In their paper published in the journal Scientific Reports, the group describes three extracts of the artemisia annua plant they tested and how they fared in combating the SARS-CoV-2 virus in human lung tissue. While the main focus of the pandemic has in recent months become the vaccines that are effective for prevention of COVID-19, work continues on treatments for those unvaccinated people who become infected with the SARS-CoV-2 virus.

Therapeutic opportunities of edible antiviral plants for COVID-19

Horticulturae, Free Full-Text

In vitro efficacy of Artemisia extracts against SARS-CoV-2, Virology Journal

Phenolic compounds versus SARS-CoV-2: An update on the main findings against COVID-19 - ScienceDirect

Coronavirus: What do we know about the artemisia plant?

Leveraging knowledge of Asian herbal medicine and its active compounds as COVID-19 treatment and prevention

Researchers evaluate artemisinin for COVID-19 management

Covid 19 coronavirus: Medsafe blocks sales of 'treatment' Artemisia annua - NZ Herald

Enhanced Antimalarial Activity of Extracts of Artemisia annua L. Achieved with Aqueous Solutions of Salicylate Salts and Ionic Liquids